
Beau Bosko Toskich/mayoclinic.org
Mar 31, 2025, 18:15
Beau Bosko Toskich: Clinical and Dosimetric Guidelines for Y-90 Glass Microsphere Radioembolization
Beau Bosko Toskich, Professor of Radiology and Director of Interventional Oncology at Mayo Clinic Florida, posted on X about recent paper he and his colleagues co-authored:
“Our international working group is proud to present multidisciplinary recommendations for the treatment of intrahepatic cholangiocarcinoma, colorectal carcinoma, and neuroendocrine carcinoma using Y90 glass microsphere radioembolization.”
Clinical and dosimetric considerations for yttrium-90 glass microspheres radioembolization of intrahepatic cholangiocarcinoma, metastatic colorectal carcinoma, and metastatic neuroendocrine carcinoma: recommendations from an international multidisciplinary working group
Authors: Marnix Lam, et al.
More posts featuring Beau Bosko Toskich.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 14:35
Apr 1, 2025, 14:08
Apr 1, 2025, 12:48
Apr 1, 2025, 12:16